Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R De Maria

Showing results (141-150 of 155) with videos related to

Pageof 16
Sort By:
Cell Death & Disease|May 10, 2014
Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivoM Signore, F Pelacchi, S di Martino, et al.
Cell Death and Differentiation|November 26, 2011
Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapyM Bartucci, S Svensson, P Romania, et al.
Oncogene|May 3, 2011
Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancerM Musumeci, V Coppola, A Addario, et al.
Oncogene|February 18, 2014
TAZ is required for metastatic activity and chemoresistance of breast cancer stem cellsM Bartucci, R Dattilo, C Moriconi, et al.
Oncogene|June 16, 2015
A microRNA code for prostate cancer metastasisD Bonci, V Coppola, M Patrizii, et al.
Oncogene|February 14, 2017
C-Met/miR-130b axis as novel mechanism and biomarker for castration resistance state acquisitionA Cannistraci, G Federici, A Addario, et al.
Veterinary and Comparative Oncology|May 6, 2016
Prolongation of survival of dogs with oral malignant melanoma treated by en bloc surgical resection and adjuvant CSPG4-antigen electrovaccinationL A Piras, F Riccardo, S Iussich, et al.
Cell Death and Differentiation|September 8, 2015
Dynamic regulation of the cancer stem cell compartment by Cripto-1 in colorectal cancerF Francescangeli, P Contavalli, M L De Angelis, et al.
Journal of Hematology & Oncology|October 31, 2019
Immunotherapy in HER2-positive breast cancer: state of the art and future perspectivesE Krasniqi, G Barchiesi, L Pizzuti, et al.
Oncogene|April 4, 2017
Noncanonical GLI1 signaling promotes stemness features and in vivo growth in lung adenocarcinomaA Po, M Silvano, E Miele, et al.
Pageof 16

Showing results (141-150 of 155) with videos related to

Sort By:
Pageof 16
Cell Death & Disease|May 10, 2014
Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivoM Signore, F Pelacchi, S di Martino, et al.
Cell Death and Differentiation|November 26, 2011
Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapyM Bartucci, S Svensson, P Romania, et al.
Oncogene|May 3, 2011
Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancerM Musumeci, V Coppola, A Addario, et al.
Oncogene|February 18, 2014
TAZ is required for metastatic activity and chemoresistance of breast cancer stem cellsM Bartucci, R Dattilo, C Moriconi, et al.
Oncogene|June 16, 2015
A microRNA code for prostate cancer metastasisD Bonci, V Coppola, M Patrizii, et al.
Oncogene|February 14, 2017
C-Met/miR-130b axis as novel mechanism and biomarker for castration resistance state acquisitionA Cannistraci, G Federici, A Addario, et al.
Veterinary and Comparative Oncology|May 6, 2016
Prolongation of survival of dogs with oral malignant melanoma treated by en bloc surgical resection and adjuvant CSPG4-antigen electrovaccinationL A Piras, F Riccardo, S Iussich, et al.
Cell Death and Differentiation|September 8, 2015
Dynamic regulation of the cancer stem cell compartment by Cripto-1 in colorectal cancerF Francescangeli, P Contavalli, M L De Angelis, et al.
Journal of Hematology & Oncology|October 31, 2019
Immunotherapy in HER2-positive breast cancer: state of the art and future perspectivesE Krasniqi, G Barchiesi, L Pizzuti, et al.
Oncogene|April 4, 2017
Noncanonical GLI1 signaling promotes stemness features and in vivo growth in lung adenocarcinomaA Po, M Silvano, E Miele, et al.
Pageof 16